Search Query :
10IA
Structure of chk1 10-pt. mutant complex with macrocyclic lrrk2 inhibitor compound 12 ((10as,13as)-3-cyclopropyl-1-methyl-8-(trifluoromethyl)-3,4,10a,11,13a,14-hexahydro-10h,13h-9,5-(azeno)furo[3,4-k]pyrazolo[4,3-b][1,4,6,10]oxatriazacyclotridecine) Deposition Author(s): Palte, R.L. , Yu, E.C. , Zhou, H.
Date: 2026-01-21 Method: X-RAY DIFFRACTION Resolution: 1.739 Å Organism(s): Homo Sapiens Sequences Data: 10IA_A
10IJ
S305i frontotemporal lobar degeneration (ftld) type i tau filament Deposition Author(s): Merz, G.E. , Pan, H.S. , Southworth, D.R. , Tse, E.
Date: 2026-01-21 Method: ELECTRON MICROSCOPY Resolution: 3.1 Å Organism(s): Homo Sapiens Sequences Data: 10IJ_A , 10IJ_B , 10IJ_C , 10IJ_D , 10IJ_E , 10IJ_F , 10IJ_G , 10IJ_H , 10IJ_I , 10IJ_J , 10IJ_K
10IK
S305i frontotemporal lobar degeneration (ftld) type ii tau filament Deposition Author(s): Merz, G.E. , Pan, H.S. , Southworth, D.R. , Tse, E.
Date: 2026-01-21 Method: ELECTRON MICROSCOPY Resolution: 3.2 Å Organism(s): Homo Sapiens Sequences Data: 10IK_A , 10IK_B , 10IK_C , 10IK_D , 10IK_E , 10IK_F , 10IK_G , 10IK_H , 10IK_I , 10IK_J
10JT
Crystal structure of kirsten rat sarcoma g12c complexed with gmppnp and covalently bound to 1-[(2r,3r)-3-{[(7p)-7-(8-ethynyl-7-fluoronaphthalen-1-yl)-8-fluoro-2-{ [(2r,4r,7as)-2-fluorotetrahydro-1h-pyrrolizin-7a(5h)-yl]methoxy}pyrido[4,3-d] pyrimidin-4-yl](methyl)amino}-2-methylpyrrolidin-1-yl]-3-(pyrazin-2-yl)propan-1-one Deposition Author(s): Sheriff, S.
Date: 2026-01-22 Method: X-RAY DIFFRACTION Resolution: 1.489 Å Organism(s): Homo Sapiens Sequences Data: 10JT_A , 10JT_B
10KR
Cryo-em structure of tau filament Deposition Author(s): Baker, M. , Banerjee, V. , Gorksi, D. , Soto, C.
Date: 2026-01-25 Method: ELECTRON MICROSCOPY Resolution: 3.57 Å Organism(s): Homo Sapiens Sequences Data: 10KR_A , 10KR_E , 10KR_B , 10KR_D , 10KR_C , 10KR_F , 10KR_J , 10KR_G , 10KR_I , 10KR_H
10KZ
N-alkyl & n-aryl aminopyrazole spirocarbamates: a two-pronged lead optimization strategy to identify orally bioavailable plasma kallikrein inhibitors Deposition Author(s): Cheng, A. , Chernyak, N. , Ellsworth, K. , Esmay, J. , Fier, P. , He, J. , Hicks, J. , Hruza, A. , Lin, K. , Lopez, J.A. , Mandal, M. , Merchant, R.R. , Ogawa, A. , Piou, T. , Rearden, P. , Sharp, P.P. , Sinz, C. , Tatosian, D.A. , Yang, S.
Date: 2026-01-26 Method: X-RAY DIFFRACTION Resolution: 1.78 Å Organism(s): Homo Sapiens Sequences Data: 10KZ_A
10LR
N-alkyl & n-aryl aminopyrazole spirocarbamates: a two-pronged lead optimization strategy to identify orally bioavailable plasmakallikrein inhibitors complex with compound 4 ((3'r)-1'-(5-amino-1-benzyl-1h-pyrazole-4-carbonyl)-6-chloro-5-fluorospiro[[3,1]benzoxazine-4,3'-piperidin]-2(1h)-one) Deposition Author(s): Cheng, A. , Chernyak, N. , Ellsworth, K. , Esmay, J. , Fier, P. , He, J. , Hicks, J. , Hruza, A. , Lin, K. , Lopez, J.A. , Mandal, M. , Merchant, R.R. , Ogawa, A. , Piou, T. , Rearden, P. , Sharp, P.P. , Sinz, C. , Tatosian, D.A. , Yang, S.
Date: 2026-01-27 Method: X-RAY DIFFRACTION Resolution: 1.583 Å Organism(s): Homo Sapiens Sequences Data: 10LR_A
10MU
Sars-cov-2 s2 in complex with polyclonal fab_donor2 Deposition Author(s): Park, S. , Ward, A.B.
Date: 2026-01-28 Method: ELECTRON MICROSCOPY Resolution: 3.16 Å Organism(s): Homo Sapiens , Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 10MU_A , 10MU_B , 10MU_C , 10MU_D , 10MU_E
10MV
N-alkyl & n-aryl aminopyrazole spirocarbamates: a two-pronged lead optimization strategy to identify orally bioavailable plasma kallikrein inhibitors complex with compound 15 ((3'r)-1'-(5-amino-1-phenyl-1h-pyrazole-4-carbonyl)-6-chloro-5-fluorospiro[[3,1]benzoxazine-4,3'-piperidin]-2(1h)-one) Deposition Author(s): Cheng, A. , Chernyak, N. , Ellsworth, K. , Esmay, J. , Fier, P. , He, J. , Hicks, J. , Hruza, A. , Lin, K. , Lopez, J.A. , Mandal, M. , Merchant, R.R. , Ogawa, A. , Ogawa, A. , Piou, T. , Rearden, P. , Sharp, P.P. , Sinz, C. , Tatosian, D.A. , Yang, S.
Date: 2026-01-28 Method: X-RAY DIFFRACTION Resolution: 1.66 Å Organism(s): Homo Sapiens Sequences Data: 10MV_A
10MW
N-alkyl & n-aryl aminopyrazole spirocarbamates: a two-pronged lead optimization strategy to identify orally bioavailable plasma kallikrein inhibitors compound 25 ((3'r)-1'-{(1p)-5-amino-1-[2-(trifluoromethoxy)phenyl]-1h-pyrazole-4-carbonyl}-6-chloro-5-fluorospiro[[3,1]benzoxazine-4,3'-piperidin]-2(1h)-one) Deposition Author(s): Cheng, A. , Chernyak, N. , Ellsworth, K. , Esmay, J. , Fier, P. , Hicks, J. , Hruza, A. , Je, J. , Lin, K. , Lopez, J.A. , Mandal, M. , Merchant, R.R. , Ogawa, A. , Poiou, T. , Rearden, P. , Sharp, P.P. , Sinz, C. , Tatosian, D.A. , Yang, S.
Date: 2026-01-28 Method: X-RAY DIFFRACTION Resolution: 1.62 Å Organism(s): Homo Sapiens Sequences Data: 10MW_A